🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In asthmatics with airway hyperresponsiveness and a "T2 immune signature" (...
Status
Completed
Location
Firestone Institute for Respiratory Health, St. Joseph's Healthcare
Start Date
2019-07-01
Trial ID
NCT03884842
Treatments Being Tested
Food allergy is a serious public health concern that causes potentially-lif...
Status
Completed
Location
University of California Los Angeles (UCLA)
Start Date
2020-02-05
Trial ID
NCT03679676
Treatments Being Tested
The Goal of this study is to investigate if individuals ages 12 years and o...
Status
Active Not Recruiting
Location
Boston Children's Hospital
Start Date
2021-09-08
Trial ID
NCT03694158
The investigators believe that administering Dupilumab during the pre- and ...
Status
Completed
Location
Centre Hospitalier de l'Université de Montréal (CHUM)
Start Date
2021-05-25
Trial ID
NCT04596189
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab in children 6 to ...
Status
Completed
Location
Investigational Site Number 840031
Start Date
2017-04-21
Trial ID
NCT02948959
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab, compared with pl...
Status
Completed
Location
Investigational Site Number 840022
Start Date
2015-10-15
Trial ID
NCT02528214
The goal of this study is to test the efficacy of Dupixent in improving pos...
Status
Recruiting
Location
Akron Children's Hospital
Start Date
2024-11-21
Trial ID
NCT06226610
The purpose of this study is to find a more effective treatment for allergi...
Status
Terminated
Location
Emory Hospital Midtown-Otolaryngology
Start Date
2023-10-26
Trial ID
NCT05545072
Treatments Being Tested
The goal of this clinical trial is to learn if dupilumab works to treat sev...
Status
Recruiting
Location
National University Hospital
Start Date
2025-11-27
Trial ID
NCT07091175
Primary Objective: To evaluate the efficacy of dupilumab (SAR231893 / REGN...
Status
Completed
Location
Investigational Site Number 840047
Start Date
2015-04-27
Trial ID
NCT02414854